TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 42 filers reported holding TALIS BIOMEDICAL CORP in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 175 | -97.1% | 0.00% | – |
| Q1 2022 | $9,000 | -62.5% | 6,075 | +0.5% | 0.00% | – |
| Q4 2021 | $24,000 | -89.7% | 6,044 | -83.7% | 0.00% | – |
| Q3 2021 | $232,000 | -45.3% | 37,115 | -3.4% | 0.00% | – |
| Q2 2021 | $424,000 | -16.5% | 38,414 | -2.9% | 0.00% | -100.0% |
| Q1 2021 | $508,000 | – | 39,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|